The latest update is out from Prelude Therapeutics (PRLD).
The Company has released a new corporate presentation and will soon unveil an educational video series focusing on SMARCA degraders. This material, including presentation slides, is accessible to the public through the Investor Relations section of their website. While this information is being shared for informational purposes, it has not been filed for regulatory purposes and is not intended to be legally binding under the Securities Exchange Act. For updates and important disclosures, investors are encouraged to regularly check the Company’s investor website.
See more data about PRLD stock on TipRanks’ Stock Analysis page.